Headache is a significant public health issue and a major cause of work-related disability. Given that lowerincome groups suffer more frequent and more severe headaches, this study examined the associations between headaches, comorbid conditions, symptom management, and health-related job loss in 432 lowincome women. The presence of headaches, headaches and allergy symptoms combined, and a higher number of comorbid conditions were significantly associated with health-related job loss. Medication use and emergency department use patterns suggest further research related to day-to-day headache symptom management strategies, and role functioning among this vulnerable group is needed.
F rom a public health perspective, the global burden of headache is significant. According to the World Health Organization (WHO), 46% of adults suffer from headaches. 1, 2 The vast majority of headaches are benign and are classified as primary headache disorders based on the International Classification of Headache Disorders-II (ICHD-II). 3 This class of headaches predominantly includes episodic and chronic forms of tension-type headache (TTH), migraine headaches with and without aura, and cluster headaches. In the adult population, the lifetime prevalence of TTH is 52%, migraine headache is 18%, and cluster headache is 1%. 4, 5 Although TTHs may be more common, migraine headaches account for the vast majority of disability, and afflict women at nearly 3 times the rate as they do men, with 17.3% of women and 5.7% of men meeting the ICHD-II migraine criteria. 6 Up to 72% of women who present with headache symptoms meet ICHD-II criteria for episodic, chronic, or probable migraines. 7 Primarily as a result of sex differences in migraine prevalence and its associated symptom burden, headache is 1 of the top 5 disorders responsible for disability among women worldwide. 2 Headache-related disability also has a substantial adverse effect on workplace outcomes and costs. An estimated 31% of adults with migraine report losing at least 1 day of work in the prior 3 months and are absent an average of 10.7 days per year because of their headache symptoms. 8, 9 Moreover, 51% report their work productivity was reduced by at least 50%. 9 The work absenteeism associated with migraines has been estimated to result in a loss of productivity of $1,165 per individual and up to $13 billion dollars annually in the United States. 8 As with many other chronic disease states influenced by stress, behavior, and/or lifestyle factors, recent studies have found an inverse relationship between socioeconomic status and migraine prevalence. 6, 10 Using nationally representative data, Buse et al 6 found both women and men in the highestincome group were 46% and 55% less likely to have migraine headaches than those in the lowest-income bracket, respectively. Others have found that lowerincome groups experience more frequent migraine episodes, more severe pain, and more disability from migraines. 10 In isolation, the higher prevalence among and more severe symptom burden experienced by women who are socioeconomically disadvantaged (henceforth referred to as "disadvantaged") can be viewed by health care providers as one of many conditions requiring appropriate diagnosis and treatment in order to improve a patient's current quality of life. However, from a social, economic, and life course perspective, the potential impact of poorly controlled symptoms over time can be significant. For example, disadvantaged women typically work in employment sectors that do not extend paid sick leave and may be less tolerant of illness-related absences. 11, 12 Given the level of disability associated with migraines and the characteristics of their employment conditions, headache disorders may exacerbate the pre-existing vulnerability of disadvantaged women to periods of recurrent unemployment and economic instability. As nurse practitioners providing primary care to this population, we need to better understand the unique risks that might be incurred by this group that could negatively impact their economic stability. Despite this, little is known about the impact of headaches on employment among disadvantaged women in particular. Therefore, the purpose of this study was to examine the relationships among headaches as a chronic health condition (CHC), health care system and medication use patterns for headaches, and employment history among disadvantaged women. More specifically, the aims of the study were as follows:
1. To describe (a) the frequency of self-reported headaches, (b) health care use patterns related to headaches, and (c) patterns of medication use for headaches 2. To examine (a) the association between selfreported headaches as a CHC and recent health-related job loss and (b) assess the strength of this association relative to other high-prevalence chronic health conditions among a sample of socioeconomic status disadvantaged women.
METHODS
This study was conducted as a secondary analysis of existing data using a descriptive, multivariate correlational cross-sectional design. Approval was granted from 2 university institutional review boards affiliated with the first author for both data collection and analysis.
Sample
The study uses baseline data from a recent randomized controlled trial that tested a public health nursing case management intervention with 432 disadvantaged women in North Central Florida between 2005 and 2010. Details of the intervention development, randomized controlled trial methods, and other health and employment-related study findings are reported elsewhere. [13] [14] [15] Women in the sample were all unemployed at baseline and had to either self-report having at least 1 health condition considered "chronic" that had been diagnosed by a health provider or have met depression, general anxiety disorder, or post-traumatic stress disorder criteria using Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders modules. 16 These criteria were selected given the potential for these conditions to interfere with physical, social, and/or emotional functioning. Chronic health conditions were defined as "conditions that are generally not cured, once acquired." Baseline sociodemographic sample characteristics are presented in Table 1 . Women in this sample were predominantly black (56.3%), single (88.4%), relatively young (x age ¼ 29.8 years), and had a lower level of education (60.2% had a high school diploma/general equivalency diploma [GED] or less). All women enrolled in the study were receiving Medicaid at the time baseline data were collected.
Measures
Study participants provided self-reported data; they completed a comprehensive health-related questionnaire. The questionnaire included health historyerelated questions commonly asked during a primary care visit, investigator-constructed questions, and a battery of standardized instruments to measure select health outcomes (ie, the Medical Outcomes Study [MOS] Short-Form 12 Version 2 and the Patient Health Questionnaire-9, among others).
The investigator-constructed items asked participants to select the CHCs they had been diagnosed with by a health care provider from a comprehensive list. The presence of "headache" as a CHC was identified by women when completing this checklist without further specification of headache type. For each CHC selected, they were asked to provide information on how long they had had the condition (in years), the number of emergency department (ED) visits made in the past year for the specified condition, and the medications taken for the specific condition. Headache medication use data were collected in narrative form and recoded by the study principal investigator into the following drug class categories: triptans, ergots, b-blockers, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), controlled substances, and other over-the-counter preparations. They were also asked to respond to the following item: "In the past year, how many jobs have you had to leave due to health?"
Data Analysis
Data analyses were conducted using Stata/SE Version 13.0 (StataCorp LP, College Station, TX). 17 Descriptive statistics were used to generate means, standard deviations, and frequencies for the sociodemographic, employment, and health condition characteristics and to meet aim 1. To meet aim 2, we applied chi-square statistics and logistic regression. We used a hierarchical regression approach to meet aim 2a; we entered headache as the first independent variable into the model, followed sequentially by age, race, educational level, and the number of CHCs as covariates. To meet aim 2b, a second logistic regression model was constructed using a forward, stepwise approach with the 5 most frequently reported CHCs as independent variables. To ensure all CHCs even minimally associated with health-related job loss were represented in the final model, we set the significance criteria at .20 for model inclusion. We adjusted for age, race, and education level by locking these variables into the stepwise selection process. However, we did not adjust for the number of CHCs in this analysis because that would have introduced significant multicollinearity within the series of independent variables of interest incorporated in the model (ie, the 5 most frequently occurring CHCs). A postestimation power analysis was conducted for the full aim 2 regression model (StataCorp LP). Power was estimated using the probability of job loss with and without headache along with the intercorrelations among the independent variables in the full model, which ranged from .001 to .45. Using these parameters, a sample size of 156 was sufficient to detect the main effects of variables on the full model at a power of .80. The final analytic sample to meet aim 1 included all 432 women who completed data collection at baseline with the final sample for aim 2 including the 348 women who had been employed in the prior year (and hence could be considered "at risk" for job loss).
RESULTS
Headache was the most frequently reported CHC (52.6% [n ¼ 227]). In rank order, the next 4 included back pain (49.8%), depression (39.6%), allergies (37.5%), and anxiety (26.6%). Of the 227 women who reported headaches as a CHC, 36.6% (n ¼ 83) indicated that they made at least 1 ED visit in the prior year because of headaches. The vast majority (54.7%, n ¼ 123) with headaches were using overthe-counter medications (including NSAIDS, acetaminophen, and aspirin) to treat their symptoms. Nearly 30% (n ¼ 67) were using no medications at all for headaches, 7.6% (n ¼ 17) were using triptans, and 8% (n ¼ 18) reported taking opiates or scheduled narcotics. Among women who reported an ED visit for headaches in the prior year, 91% reported their headaches had been present for 2 or more years. In addition, 83% who were using controlled substances for headache symptoms, 53% who were taking migraine-specific medications, and 34% who were taking no medication at all for headache made at least 1 visit to the ED in the prior year. Findings from aim 2 logistic regression analyses are presented in Table 2 . The unadjusted odds of having left a job in the prior year because of health (henceforth referred to as "health-related job loss" for brevity) was nearly twice that for women who reported headache as a CHC compared with those who did not (odds ratio [OR] ¼ 1.99, P < .05). This association remained essentially unchanged as age, race, and education were sequentially added as covariates to the model. As noted in model 5 (Table 2) , when the number of CHCs was added to the model, it became a statistically significant explanatory variable (OR ¼ 1.35, P < .05), whereas the association between headache and health-related job loss was attenuated and was no longer statistically significant (OR ¼ 1.40). Also noted in Table 2 is the association between education and health-related job loss whereby women with a high school diploma or GED were approximately half as likely to have reported health-related job loss as women with less than a high school diploma or GED (models 4 and 5, OR ¼ .51 and .51, P < .05 for both).
To better understand the association between the number of CHCs, education, and health-related job loss and examine how this may differ across women with and without headaches, we conducted additional postestimation analyses based on the initial regression findings. First, we simply examined the difference in the mean number of CHCs by job loss using an independent t test; women who had reported a health-related job loss in the prior year had a slightly higher number of CHCs (x ¼ 4.7) than those who had not reported a health-related job loss (x ¼ 3.3) (P <.001). We then (separately) included interaction terms for (1) the number of CHCs and headache and (2) education level and headache to the full regression model (model 5, Table 2 ) while holding other covariates in the model constant (age, race, and education) (data not shown). The number of CHCs Â headache interaction term was not significant (OR ¼ .98, P ¼ .90), indicating there was no difference in the direction or magnitude of the relationship between having a higher (or lower) number of CHCs and health-related job loss based on whether women reported headaches. The education level Â headache interaction was also not statistically significant (OR ¼ .78, P ¼ .39), indicating there was no difference in the odds of having lost a job because of health in the prior year for women with headaches across levels of education while holding other covariates in the model constant. Finally, to examine the more nuanced relationship between headache, education, and number of CHCs on job loss, we also calculated the marginal effect of headache based on the number of CHCs and education level while adjusting for age and race. 18 Given that 93% of the sample had between 1 and 7 CHCs, we estimated the marginal effect of headaches for women at each CHC value between 1 and 7, first while holding education constant and then by examining across the 3 education levels. Although the marginal effects were not statistically significant (Figure 1) , having headaches as a CHC increases the probability of health-related job loss from 4.5% for women with 1 CHC to just over 8% for those with 6 or 7 CHCs. As depicted in Figure 2 , although not statistically significant, there are some trends in the marginal probabilities of health-related job loss for women with headaches that vary not only by the number of CHCs but also by level of education. Specifically, these marginal effect trends suggest headache accounts for a 6% to 8.5% increased probability that women with less than a 12th grade education had a health-related job loss if they had between 1 to 5 CHCs, whereas the probability for women with a high school diploma/GED and those with any type of college education or technical training was slightly less (3.5%-7.5%) if they had between 1 and 5 CHCs. These marginal effects increase as the number of CHCs increase across all groups until they converge at 6 CHCs, where the Note: Job loss is specific to health-related job loss in prior year. Average marginal effects depict the marginal, or "additional," or "unique" effect of having headache as a chronic health condition on the probability of health-related job loss in the prior year. Note: Job loss is specific to health-related job loss in prior year. Average marginal effects depict the marginal, or "additional," or "unique" effect of having headache as a chronic health condition on the probability of health-related job loss in the prior year stratified by education level.
probability is essentially the same for women regardless of education level (8%).
When the 5 most frequently occurring CHCs (headache, back pain, depression, allergies, and anxiety) were directly compared with one another as predictors of health-related job loss, only headaches and allergies were significant (P ¼ .004 and .02, respectively) while adjusting for age, race, and education (see Table 3 ). Back pain, depression, and anxiety were not significant independent predictors of health-related job loss, even though the significance criteria for inclusion in the model was set liberally (P ¼ .20). This finding indicates that, across the 5 most prevalent disorders, headache is one of the CHCs most associated with job loss, as is having allergies. A headache Â allergies interaction term added to the model indicated that women who reported both headaches and allergies as CHCs were nearly 3 times as likely to have had a job loss compared with those who had neither headaches nor allergies (OR ¼ 2.9, P .001, data not shown).
Study Limitations
There are limitations of this study that should be noted. First, given the way in which CHC data were collected during the primary study, we are unable to discern which women in the sample with headaches met diagnostic criteria for migraine as opposed to some other form of headache. In this sample, women identified whether they had headaches as a CHC that had been diagnosed by a provider but without specificity regarding headache type. Based on the demographic and health-related composition of the study sample, it is reasonable to presume the vast majority were suffering from some form of a primary headache disorder. Given that at least 1 study found 72% of women presenting to primary care clinics with headaches met diagnostic criteria for migraine 7 and the prevalence of migraine among lower-income women is 1.5 times that of women in higher-income groups (20.6% vs 13.6%, respectively), 6 it follows that a high proportion of women with headaches in this study sample would also likely meet ICHD-II diagnostic criteria for episodic, chronic, or probable migraines. 3 Although this likelihood is high, the lack of a definitive diagnosis makes comparing our findings with those of other studies, most of which relate to migraine, tenuous. Second, although we had a large enough sample to detect the main effects in our regression models for aim 2, it is possible that there was not sufficient power to detect the interactions and more nuanced marginal effect gradients that were explored post hoc; thus, the inferences that can be drawn from the trends that were not statistically significant should be considered only trends and require further exploration in a larger sample. Despite these limitations, the findings do make a novel contribution to our understanding of the extent to which headache is associated with recent healthrelated job loss among disadvantaged women.
DISCUSSION AND RECOMMENDATIONS
Overall, these findings suggest that low-income women who report headache as a CHC are twice as likely to have lost a job in the prior year because of health regardless of age, race, or education level. Two other factors played an important role in this relationship: a higher number of chronic health conditions and having both headache and allergies as comorbid conditions. In the context of a greater number of CHCs, headache becomes less relevant in explaining job loss, whereas having both headache and allergies increases the likelihood of job loss above and beyond having either of these conditions alone. In addition, although nuanced, trends in our data suggest women with headaches who also have less than a high school education or GED may be at a somewhat greater risk for job loss than those with more education when they have between 1 and 5 CHCs. These findings are consistent with other findings in the literature. For example, Ku et al 19 found the prevalence of migraines was much higher among adults with allergic rhinitis (34%) than in nonatopic, nonrhinitis controls (2%). Recent study findings further suggest adults with both a diagnosis of migraine and rhinitis symptoms have greater headache days per month and headache-related disability than those who do not report rhinitis of a "mixed" etiology (ie, with both allergic and nonallergic triggers). 20 Perhaps most relevant for nurse practitioners and other providers, our findings also suggest headache symptoms among disadvantaged women may be poorly controlled and/or managed within the current health care system. Only 56% of adults who meet migraine criteria are aware their headaches are migraines, 21 and only 26% of adults with significant migraine-related functional impairment who accessed care received an appropriate diagnosis and/or migraine-specific treatment. 22 Current evidencebased guidelines recommend a stratified treatment approach for migraines that urges clinicians to take into account several factors in treatment decision making. These include pain intensity, degree of disability, and comorbid conditions, among others. 23 Although recommended first-line medications for acute migraine can include simple analgesics such as aspirin, acetaminophen, and/or NSAIDS, triptans are considered the mainstay of migraine treatment unless contraindicated. Based on 2009 ambulatory care data, when prescription medications are given to treat migraine, 82% are for triptans. 24 Although migraine status was not definitively established in the current sample, the pattern of medication use in this sample differs somewhat from other published findings of acute treatment for episodic migraine in the adult population where over-the-counter preparations were used by 68%, 32% were using no medications, 19.3% were using migraine-specific medications, and opiates or butalbital-containing compounds were used by 11.1% and 6%, respectively. 21 Given the higher likelihood that many in our sample would meet migraine or probable migraine criteria, very few women in our sample were using triptans (7.6%) compared with triptan use among adults with migraines in the general population (19.3%). 21 Compared with the 7.3% of adults with migraines in the ongoing American Migraine Prevalence and Prevention study cohort who reported an ED visit in the prior year for headaches, 24 the 36.6% of women in our study who visited the ED for headaches in the prior year was remarkably high. This is particularly so when the vast majority (91%) who made an ED visit also reported their headaches were present for 2 or more years. There are several factors that could account for higher ED use in this group. First, although all women in the study were receiving Medicaid at the time these data were collected, many probably lacked health insurance at some point in the prior year, which may have limited primary care access. Second, it is equally likely the result of poor overall headache symptom management by the women themselves, their health care providers, or both. Among women who were taking migrainespecific medications (triptans or ergots) for headaches, more than 50% had an ED visit in the prior year specifically for their headache symptoms.
For nurse practitioners who provide care to this population, these findings suggest a need for more extensive headache symptom evaluation and screening, education on symptom management, and regular monitoring of treatment efficacy. Given the association of headaches with job loss in this group, particularly in the context of a greater number of CHCs generally and when allergies are also present, providers should be explicitly asking women how their headaches may or may not be interfering with functioning at work and elsewhere. This conversation should include what symptom triggers may be precipitated by their employment settings or roles and what their symptom management strategies are when headaches occur on work days and/or while at work. Given the need for many disadvantaged women to provide economic support for their families and the characteristics of the jobs held by this group, ensuring headache symptoms are not contributing to health-related job loss is imperative.
Finally, further research is needed. Although studies have shown lower-income groups have a higher prevalence of migraines and more functional impairment from migraines, little is known about how disadvantaged women are managing their headache symptoms, how their choice of management may be affecting symptoms related to other comorbid conditions, and how their management strategies may be impacting their functioning in select roles (particularly with regard to employment). Studies have shown the national impact that headaches have in terms of lost productivity and wages, and clinical trials have shown an estimated 31% to 35% of the productivity loss can be reversed solely with the use of triptans. 25, 26 Generally, however, studies of the symptom management strategies used by disadvantaged women and how these might affect role functioning and work performance are lacking. Additional research in this area is needed to determine the development of interventions that are more culturally tailored to the daily realities of the employment conditions and demands of this group.
CONCLUSIONS
The presence of headaches and a higher number of CHCs increases the probability of health-related job loss for disadvantaged women. This risk is exacerbated when allergies co-occur and may be increased with higher numbers of CHCs and for women with lower levels of education. The care nurse practitioners provide is often focused on underserved populations as well as prevention and symptom management. As such, nurse practitioners are well suited for not only tailoring pharmacologic headache therapy to individual patient characteristics but also for providing the additional education, cognitive behavioral therapies, and/or symptom monitoring that disadvantaged women may need for optimal headache symptom management. This is essential to minimize not only headache-related disability but also to ensure headaches do not contribute to job loss and further economic instability for this vulnerable population.
